# Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

> **NCT00502684** · NA · UNKNOWN · sponsor: **Kaplan Medical Center** · enrollment: 32 (estimated)

## Conditions studied

- Primary Operable Breast Cancer

## Interventions

- **DRUG:** Propranolol, etodolac

## Key facts

- **NCT ID:** NCT00502684
- **Lead sponsor:** Kaplan Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2014-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502684, "Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00502684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*